Added to basket
Unapplied Changes
Celora Vita has been introduced to the UK market by DermaFocus as part of its expanding regenerative portfolio. This new launch sees Dermafocus making its next strategic step into a brand owner and leader in regenerative aesthetics.
Addressing skin ageing at its source
Celora Vita is an injectable formulation medical device intended for intradermal administration to support full facial skin biorestoration and overall skin quality improvement.
Its formulation combines a targeted blend of nine amino acids selected for their role in collagen synthesis, elastin production, and complete extracellular matrix renewal, with low molecular weight hyaluronic acid chosen for its ability to support dermal hydration and microenvironment support.
This composition reflects a deliberate shift away from volumisation and towards substrate-based biorestoration, supplying the dermis with the essential building blocks required for healthy, resilient skin.
The science behind the injectable
Celora Vita is one of the most complete amino acid blends in its class and is designed for physiological regeneration, supporting long-term skin quality and durability.
The amino acids in Celora Vita have each been selected because they play a precise and complementary role in complete extracellular matrix renewal.
What results can practitioners expect?
Clinical evidence demonstrates measurable improvements across key skin quality parameters, including:
- Hydration
- Natural radiance
- Firmness and elasticity
- Skin texture
- Fine lines and wrinkles
Together, these outcomes contribute to comprehensive skin quality enhancement.
Celora Vita has been developed to integrate seamlessly into modern aesthetic practice. The versatility of the product allows it to be incorporated across a wide range of indications and treatment plans, including early intervention and prejuvenation protocols, as well as skin quality optimisation in patients with early to moderate signs of ageing.
How does Celora Vita fit into clinical protocols?
Celora Vita sits alongside Plinest and Purasomes within the DermaFocus regenerative portfolio. For practitioners building regenerative protocols, this offers the ability to address multiple sources of skin ageing within a single structured programme.
Milad Bemana, Executive Director at DermaFocus, comments:
“Regenerative aesthetics is moving in a clear direction: practitioners want treatments that restore skin quality, not just alter appearance.
Celora Vita reflects that direction. It gives clinicians a scientifically grounded tool to address substrate deficiency something that has been overlooked for too long and it does so within a framework that integrates naturally with the protocols they are already building.”
Celora Vita is now available to purchase at Wigmore Medical. Login to your account to order.
